Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).
暂无分享,去创建一个
S. Culine | P. Biron | C. Théodore | J. Droz | C. Théodore | P. Kerbrat | A. Kramar | K. Fizazi | C. Chevreau | L. Geoffrois | L. Geoffrois | J. Bouzy | C. Chevreau | A. Caty | R. Delva | N. B. Bui | J. Pény | N. Bui
[1] Alan Horwich,et al. Testicular germ-cell cancer , 2006, The Lancet.
[2] J. Bacik,et al. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] W. Siegert,et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] M. Stockler,et al. Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial , 2001, The Lancet.
[5] S. Culine,et al. Comparative Tolerability of Chemotherapy Regimens for Germ Cell Cancer , 2000, Drug safety.
[6] L. Einhorn,et al. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] L. Collette,et al. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] S. Culine,et al. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial. , 1997, The Journal of urology.
[9] Richard Sylvester,et al. International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers , 1997 .
[10] L. Einhorn,et al. Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] S. Kaye,et al. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] V. Harvey,et al. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] L. Einhorn. Treatment of testicular cancer: a new and improved model. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] M. McKeage,et al. Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomycin lung. New Zealand Clinical Oncology Group. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] L. Einhorn,et al. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] N. Geller,et al. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] C. Théodore,et al. Prognostic factors in advanced nonseminomatous testicular cancer a multivariate logistic regression analysis , 1988, Cancer.
[18] L. Einhorn,et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. , 1987, The New England journal of medicine.
[19] A. Satterfield,et al. TREATMENT , 1924, California and western medicine.
[20] A. Miller,et al. Reporting results of cancer treatment , 1981, Cancer.